<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:a2f3af11-73fc-4417-a5c9-2338eaa01361,g:25314231-c3cc-4ce2-9247-6c3b742c9ab4,d:b77063184aa24067a876dbbfbf583881--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>smmt-20220511</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV80L2ZyYWc6ZDI0ODkyZThkNDcyNDM1OTg2NDk2NTg5Mzg4ZDI4NzAvdGFibGU6MzQ1NTZkODMzYWViNDgwODkzNGVhNWY2NDU5YTQ2Y2QvdGFibGVyYW5nZTozNDU1NmQ4MzNhZWI0ODA4OTM0ZWE1ZjY0NTlhNDZjZF8wLTEtMS0xLTY3MzY1_c8eac33a-a1be-451a-bd1e-cc6bdd97541c">0001599298</ix:nonNumeric><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV80L2ZyYWc6ZDI0ODkyZThkNDcyNDM1OTg2NDk2NTg5Mzg4ZDI4NzAvdGFibGU6MzQ1NTZkODMzYWViNDgwODkzNGVhNWY2NDU5YTQ2Y2QvdGFibGVyYW5nZTozNDU1NmQ4MzNhZWI0ODA4OTM0ZWE1ZjY0NTlhNDZjZF8xLTEtMS0xLTY3MzY1_f2fbb02c-bf48-42cf-9eb8-6fecb75360d7">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="smmt-20220511.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i1326669906be4a58bf6114174d794f32_D20220511-20220511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001599298</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-11</xbrli:startDate><xbrli:endDate>2022-05-11</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ib77063184aa24067a876dbbfbf583881_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">FORM <ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGV4dHJlZ2lvbjowMGY4NTJkN2RmNzQ0ZDE4ODgxY2EyNTIwYTE3M2FmYl8yNTE4_0e1eb558-4767-4408-8189-262e84d2fbd5">8-K</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Date of Report (Date of Earliest Event Reported): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline"><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGV4dHJlZ2lvbjowMGY4NTJkN2RmNzQ0ZDE4ODgxY2EyNTIwYTE3M2FmYl8yMjg_58e644b6-f995-4ac3-b5cb-8ed4dbe55df2">May 11, 2022</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></div><div style="padding-left:5.65pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGFibGU6NzgzMTVkYTcwM2MyNDg1NzljMzBkNGQxOTlhNjg4YzEvdGFibGVyYW5nZTo3ODMxNWRhNzAzYzI0ODU3OWMzMGQ0ZDE5OWE2ODhjMV8wLTAtMS0xLTY3MzY1_c542bce5-b277-4ed2-b90e-905aa9e9c0e4">Summit Therapeutics Inc.</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(Exact Name of Registrant as Specified in Its Charter)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 4.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 4.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGFibGU6NzgzMTVkYTcwM2MyNDg1NzljMzBkNGQxOTlhNjg4YzEvdGFibGVyYW5nZTo3ODMxNWRhNzAzYzI0ODU3OWMzMGQ0ZDE5OWE2ODhjMV8zLTAtMS0xLTY3MzY1_5a88e77a-f14b-4d8f-9228-c89148721822">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGFibGU6NzgzMTVkYTcwM2MyNDg1NzljMzBkNGQxOTlhNjg4YzEvdGFibGVyYW5nZTo3ODMxNWRhNzAzYzI0ODU3OWMzMGQ0ZDE5OWE2ODhjMV8zLTEtMS0xLTY3MzY1_549f81c0-9201-4d2d-9f73-6c18f0d70edd">001-36866</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGFibGU6NzgzMTVkYTcwM2MyNDg1NzljMzBkNGQxOTlhNjg4YzEvdGFibGVyYW5nZTo3ODMxNWRhNzAzYzI0ODU3OWMzMGQ0ZDE5OWE2ODhjMV8zLTItMS0xLTY3MzY1_111b7dab-42a8-4307-93a6-869a9eed4721">37-1979717</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(State or Other Jurisdiction<br/>of Incorporation)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(Commission<br/>File Number)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(IRS Employer<br/>Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 4.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 4.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGFibGU6NzgzMTVkYTcwM2MyNDg1NzljMzBkNGQxOTlhNjg4YzEvdGFibGVyYW5nZTo3ODMxNWRhNzAzYzI0ODU3OWMzMGQ0ZDE5OWE2ODhjMV82LTAtMS0xLTY3MzY1L3RleHRyZWdpb246OTQ4ZDMyNjcyZTA3NGM4ZDk1NjZkZmUzYzY3NjY5ZjBfNQ_9cbe1031-28ee-4dcb-9a11-ae75490447e8">One Broadway, 14th&#160;Floor</ix:nonNumeric>, <ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGFibGU6NzgzMTVkYTcwM2MyNDg1NzljMzBkNGQxOTlhNjg4YzEvdGFibGVyYW5nZTo3ODMxNWRhNzAzYzI0ODU3OWMzMGQ0ZDE5OWE2ODhjMV82LTAtMS0xLTY3MzY1L3RleHRyZWdpb246OTQ4ZDMyNjcyZTA3NGM4ZDk1NjZkZmUzYzY3NjY5ZjBfOQ_81439677-0962-45a0-90ce-7358caa17856">Cambridge</ix:nonNumeric>, <ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGFibGU6NzgzMTVkYTcwM2MyNDg1NzljMzBkNGQxOTlhNjg4YzEvdGFibGVyYW5nZTo3ODMxNWRhNzAzYzI0ODU3OWMzMGQ0ZDE5OWE2ODhjMV82LTAtMS0xLTY3MzY1L3RleHRyZWdpb246OTQ4ZDMyNjcyZTA3NGM4ZDk1NjZkZmUzYzY3NjY5ZjBfMTM_eb13ced7-fc08-4eec-ad9f-85dd884d4090">MA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGFibGU6NzgzMTVkYTcwM2MyNDg1NzljMzBkNGQxOTlhNjg4YzEvdGFibGVyYW5nZTo3ODMxNWRhNzAzYzI0ODU3OWMzMGQ0ZDE5OWE2ODhjMV82LTItMS0xLTY3MzY1_0a1bcbd4-4658-44fc-a31f-155d63490ce0">02142</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(Zip Code)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Registrant&#8217;s Telephone Number, Including Area Code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline"><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGV4dHJlZ2lvbjowMGY4NTJkN2RmNzQ0ZDE4ODgxY2EyNTIwYTE3M2FmYl8yODk_1f54ade4-eab5-4d04-8980-543335941968">617</ix:nonNumeric>-<ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGV4dHJlZ2lvbjowMGY4NTJkN2RmNzQ0ZDE4ODgxY2EyNTIwYTE3M2FmYl8yNTE5_6698205e-e18c-452c-8069-da78dc05dfb1">514-7149</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></div><div style="padding-left:5.65pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Not Applicable</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(Former Name or Former Address, If Changed Since Last Report)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> General Instruction A.2. below):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGV4dHJlZ2lvbjowMGY4NTJkN2RmNzQ0ZDE4ODgxY2EyNTIwYTE3M2FmYl8yNTIx_801e4ac9-4799-4154-adf1-9f4fe2842a5b">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGV4dHJlZ2lvbjowMGY4NTJkN2RmNzQ0ZDE4ODgxY2EyNTIwYTE3M2FmYl8yNTE1_7e50e871-e9a2-4c0f-a996-99ca1e110579">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGV4dHJlZ2lvbjowMGY4NTJkN2RmNzQ0ZDE4ODgxY2EyNTIwYTE3M2FmYl8yNTE3_b35e4848-f35f-48cf-8624-0a2d8932dd23">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGV4dHJlZ2lvbjowMGY4NTJkN2RmNzQ0ZDE4ODgxY2EyNTIwYTE3M2FmYl8yNTEz_2ba69395-f3f9-4454-9253-d6cac8d7e44b">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:6.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Title of Each Class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGFibGU6OWI2NDIwMDYwYjJjNGFhZmE1NTI4MjM0OTY2ZWFjNzIvdGFibGVyYW5nZTo5YjY0MjAwNjBiMmM0YWFmYTU1MjgyMzQ5NjZlYWM3Ml8xLTAtMS0xLTY3MzY1_3bd50e0d-a7e9-4620-8c18-eb47ee0f7675">Common stock, $0.01&#160;par value per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGFibGU6OWI2NDIwMDYwYjJjNGFhZmE1NTI4MjM0OTY2ZWFjNzIvdGFibGVyYW5nZTo5YjY0MjAwNjBiMmM0YWFmYTU1MjgyMzQ5NjZlYWM3Ml8xLTEtMS0xLTY3MzY1_a103da75-ce95-4e8d-b9ae-458dec029563">SMMT</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGFibGU6OWI2NDIwMDYwYjJjNGFhZmE1NTI4MjM0OTY2ZWFjNzIvdGFibGVyYW5nZTo5YjY0MjAwNjBiMmM0YWFmYTU1MjgyMzQ5NjZlYWM3Ml8xLTItMS0xLTY3MzY1_9cab860c-103c-457a-af32-de111c1f5fce">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Emerging growth company </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i1326669906be4a58bf6114174d794f32_D20220511-20220511" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmI3NzA2MzE4NGFhMjQwNjdhODc2ZGJiZmJmNTgzODgxL3NlYzpiNzcwNjMxODRhYTI0MDY3YTg3NmRiYmZiZjU4Mzg4MV8xL2ZyYWc6MDBmODUyZDdkZjc0NGQxODg4MWNhMjUyMGExNzNhZmIvdGV4dHJlZ2lvbjowMGY4NTJkN2RmNzQ0ZDE4ODgxY2EyNTIwYTE3M2FmYl8yNTE0_5181dba6-7541-4e82-8dcc-4cdffdd1166c">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#9744;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Item 2.02</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Results of Operations and Financial Condition.</span></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">On May 11, 2022, Summit Therapeutics Inc. announced its financial results and operational highlights for the three months ended March 31, 2022. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The information in this Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Item 9.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Financial Statements and Exhibits.</span></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(d) Exhibits</span></div><div style="padding-left:5.65pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:3pt;padding-right:3pt"><span><br/></span></div><div style="padding-left:3pt;padding-right:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit Number</span></div></td><td colspan="3" style="padding:2px 1pt 2px 4.02pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 4.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3pt;padding-right:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">99.1</span></div><div style="padding-left:3pt;padding-right:3pt"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3pt;padding-right:3pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline" href="pressreleaseq1march2022.htm">Press Release, dated May 11, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">104</span></td><td colspan="3" style="padding:2px 1pt 2px 4.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">SIGNATURES</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.</span></div><div style="padding-left:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.907%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="6" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">SUMMIT THERAPEUTICS&#160;INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="6" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="6" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Date: May 11, 2022</span></td><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">By:</span></td><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">/s/ Robert W. Duggan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Chief Executive Officer and Executive Chairman; Principal Executive Officer and Principal Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "smmt-20220511.htm", "description": "8-K", "secsgml_size_bytes": 38933}]
{"company-data": {"conformed-name": "Summit Therapeutics Inc.", "cik": "0001599298", "assigned-sic": "2834", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-36866", "film-number": "22914406"}, "business-address": {"street1": "ONE BROADWAY", "street2": "14TH FLOOR", "city": "CAMBRIDGE", "state": "MA", "zip": "02142", "phone": "617-514-7149"}, "mail-address": {"street1": "ONE BROADWAY", "street2": "14TH FLOOR", "city": "CAMBRIDGE", "state": "MA", "zip": "02142"}, "former-company": [{"former-conformed-name": "Summit Therapeutics plc", "date-changed": "20150219"}, {"former-conformed-name": "Summit Corp plc", "date-changed": "20140205"}]}
smmt-20220511
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
May 11, 2022
Summit Therapeutics Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
001-36866
37-1979717
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
One Broadway, 14th Floor
,
Cambridge
,
MA
02142
(Address of Principal Executive Offices)
(Zip Code)
Registrant's Telephone Number, Including Area Code:
617
-
514-7149
Not Applicable
(Former Name or Former Address, If Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
Trading Symbol(s)
Name of Each Exchange on Which Registered
Common stock, $0.01 par value per share
SMMT
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 2.02
Results of Operations and Financial Condition.
On May 11, 2022, Summit Therapeutics Inc. announced its financial results and operational highlights for the three months ended March 31, 2022. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information in this Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01
Financial Statements and Exhibits.
(d) Exhibits
Exhibit Number
Description
99.1
Press Release, dated May 11, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
SUMMIT THERAPEUTICS INC.
Date: May 11, 2022
By:
/s/ Robert W. Duggan
Chief Executive Officer and Executive Chairman; Principal Executive Officer and Principal Financial Officer